Diagnosis of metabolic disorders in women with polycystic ovary syndrome

Obstetrical and Gynecological Survey

Volumn 63, Issue 12, 2008, Pages 796-802

  Angioni, Stefano ^a   Portoghese, Elaine ^a   Milano, Francesca ^a   Melis, Gian Benedetto ^a   Fulghesu, Anna Maria ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C;

CLINICAL PRACTICE; COST BENEFIT ANALYSIS; DIET RESTRICTION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GOLD STANDARD; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; REVIEW; TRANSVAGINAL ECHOGRAPHY; GLUCOSE TOLERANCE TEST; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME;

EID: 64149089929     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3181895a06     Document Type: Review

References (41)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 33313:853-861.
2. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29:181-191.
3. The Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril 2004; 81:19-25.
4. Adams J, Franks S, Poison DW, et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropine-releasing hormone. Lancet 1985; 2:1375-1379.
5. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980; 50:113-116.
6. Consensus development conference on insulin resistance, 5-6 November 1997. American Diabetes Association. Diabetes Care 1998; 21:310-314.
7. Ferrannini E, Balkau B. Insulin: in search of a syndrome. Diabet Med 2002; 19:724-729.
8. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000; 85:4426-4433.
9. Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15:539-553.
10. Ferrannini E, Natali A, Bell P, et al. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 1997; 100:1166-1173.
11. Stuart CA, Peters EJ, Prince MJ, et al. Insulin resistance with acanthosis nigricans; the role of obesity and androgen excess. Metabolism 1986; 35:197-205.
12. Achard C, Thiers J. Le virilisme pilaire et son association à l'insuffisance glycolytique (diabète des femmes à barbe). Bull Acad Nati Med 1921; 86:51-83.
13. Poretsky L. On paradox of insulin induced hyperandrogenism in insulin-resistant states. Endocr Rev 1991; 12:3-13.
14. Moghetti P, Tosi F, Castello R, et al. The insulin-resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab 1996; 81:952-960.
15. Nestler JE, Jakubowicz DJ, Falcon de Vargas A, et al. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 1998; 83:2001-2005.
16. Holte J, Bergh T, Berne C, et al. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese woman with polycystic ovary syndrome. J Clin Endocrinol Metab 1995; 80:2586-2593.
17. Nestler JE, Barlascini CO, Matt DW, et al. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese woman with polycystic ovary syndrome. J Clin Endocrinol Metab 1989; 68:1027-1032.
18. Nester JE. Sex-hormone binding globulin: a marker for hyperinsulinemia and/or insulin-resistance? J Clin Endocrinol Metab 1993; 76:273-274.
19. Conway GS, Jacobs HS, Holly JMP, et al. Effects of luteinizing hormone, insulin, insulin-like growth factor-binding protein in patients with polycystic ovary syndrome. Hum Reprod 1989; 4:136-139.
20. Homburg R. Pariente C, Lunelef B, et al. The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein 1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome. Hum Reprod 1992; 7:1379-1383.
21. Moghetti P, Castello R, Negri C, et al. Insulin infusion amplifies 17α-Hydroxycorticosteroid intermediates response to ACTH in hyperandrogenic women: apparent relative impairment of 17, 20-lyase activity. J Clin Endocrinol Metab 1996; 81:881-886. (Pubitemid 26083940)
22. Carmina E, Lobo RA. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2004; 82:661-665. (Pubitemid 39243189)
23. Ganda OP, Day JL, Soeldner JS, et al. Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes 1978; 27:715-725. (Pubitemid 8393561)
24. Ciampelli M, Leoni F, Lanzone A, et al. Assessment of insulin sensitivity in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients. J Clin Endocrinol Metab 2005; 90:1398-1406.
25. Fulghesu AM, Angioni S, Melis GB, et al. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovarian syndrome. Fertil Steril 2006; 86:398-404. (Pubitemid 44118963)
26. Polonsky KS, Rubenstein AH. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes 1984; 33:486-494.
27. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 273:E214-E223.
28. Dunaif A, Finegood DT. β-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81:942-947. (Pubitemid 26083951)
29. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002; 19:527-534.
30. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 2694-2698.
31. Vuguin P, Saenger P, Dimartino-Nardi J. Fasting glucose insulin ratio: a useful measure of insulin resistance in girls with premature adrenarche. J Clin Endocrinol Metab 2001; 86: 4618-4621.
32. Quon MJ. Limitations of fasting glucose to insulin ratio as an index of insulin sensitivity. J Clin Endocrinol metab 2001; 86: 4615-4617.
33. Kauffman RP, Baker VM, Dimarino P, et al. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol 2002; 187:1362-1369.
34. Turner R, Holman R, Matthews D, et al. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feed-back analysis from basal plasma insulin and glucose concentration. Metabolism 1979; 28: 1086-1096.
35. Bonora E, Targher G, Alberiche M, et al. Homeostatic model assessment closely mirrors the glucose clamp tecnique in the assessment of insulin sensitivity. Diabetes Care 2000; 23:57-63.
36. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostatic model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28:412-419. (Pubitemid 15018832)
37. Yeckel CW, Weiss R, Dziura J, et al. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 2004; 89:1096-1101. (Pubitemid 38368396)
38. Diamanti-Kandarakis E, Kouli C, Alexandraki K, et al. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome. J Clin Endocr Metab 2004; 89:1273-1276.
39. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index. A simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85:2402-2410.
40. Hrebicek J, Janout V, Malincikova J, et al. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002; 87:144-147. (Pubitemid 34084683)
41. Jayagopal V, Kilpatrick ES, Jenning PE, et al. The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implication for SHBG as a surrogate marker of insulin resistance. J Clin Endocrinol Metab 2003; 88:1528-1533.